eXoZymes CSO Sells Shares Amid Bullish Surge, Yet Shares Stay Bullish as IPO Looms
Insider sales by eXoZymes’ CSO reveal routine portfolio moves amid a bullish 16% price surge and upcoming Nasdaq offering, showing confidence yet short‑term profit‑taking.
3 minutes to read